What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
9 Co-sponsors
History
- Referred to corporations, authorities and commissions
- Delivered to senate
- Passed assembly
- Amended on third reading 5321a
- Ordered to third reading cal.374
- Returned to assembly
- Died in senate
- Referred to corporations, authorities and commissions
- Delivered to senate
- Passed assembly
- Advanced to third reading cal.529
- Reported
Show 2 earlier actions
- Reported referred to ways and means
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Creates the lymphedema and lymphatic diseases research grants program
In Senate Committee · Corporations, Authorities And Commissions · Sponsor Martin J. Golden
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:A5321A
Title of bill
An act to amend the public authorities law, in relation to establishing a lymphedema and lymphatic diseases research grants program; and to amend the state finance law, in relation to creating the lymphedema and lymphatic diseases research fund
Purpose or general idea of bill
This legislation would establish a. lymphedema and lymphatic disease research grants program. Grants, not to exceed fifty thousand dollars, would be awarded on a completive basis to biomedical research institutions that are conducting direct research related to lymphedema and lymphatic disease.
Summary of specific provisions
The public authorities law is amended by adding a new section 3153-a.
Justification
This legislation would establish a lymphedema and lymp- hatic disease research grants program. Grants, not to exceed fifty thou- sand dollars, would be awarded on a completive basis to biomedical research institutions that are conducting direct research related to lymphedema and lymphatic disease.
Lymphedema is an accumulation of lymphatic fluid in the interstitial tissue that causes swelling, most often in the annes) or leges), and occasionally in other parts of the body. Lymphedema can develop when lymphatic vessels are missing" or impaired (primary), or when lymph vessels are damaged or lymph nodes removed (secondary).
Radiation therapy, used in the treatment of various cancers and some AIDS-related diseases, can damage otherwise healthy lymph nodes and vessels causing scar tissue to form which interrupts the normal flow of the lymphatic fluid.
Moreover, untreated, lymphedema can lead into a decrease or loss of functioning of the limbs, skin breakdown, and chronic infections. In the most severe cases, untreated lymphedema can develop into a rare form of lymphatic cancer.
This legislation would provide much need funding to those involved in direct research of lymphedema or lymphatic diseases. These diseases are far more common than society notes; however, funding for research has historically not kept pace to the dramatically growing need for it.
Prior legislative history
2006:A.11080 2007-08: 5.4266A - Committed to Rules 2009: A5321/ 52585 Passed Assembly; Senate Corporations Committee
Fiscal implications
Subject to available appropriations.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.